Clinical Trial

A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease

Name: A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease — clinical trial record (NCT07555054)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of the study was to evaluate the efficacy and safety of HS-10390 in participants with chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) ≥ 30 and \<90 mL/min/1.73 m\^2, and urinary albumin to creatinine ratio (UACR) ≥ 150 mg/g and \< 3000 mg/g

Trial Details

NCT Number	NCT07555054
Lead Sponsor	Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions	Chronic Kidney Disease
Enrollment	182 participants
Start Date	2026-05-21
Primary Completion	2027-11-11 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-28